Christmas is a time of celebration for many, as the occasion warrants feast and family, and the festive spirit is contagious throughout the country. Christmas disease is a much less joyous feature in people’s lives, but again is a heavy feature in families. Most famously, a type of Christmas disease had a noticeable appearance in… Read More »
In today’s world, there is basically a drug prescription for every ailment, from a sore throat to a broken ankle. We have been trained to turn to prescriptions for pain relief. In many cases, prescription drugs are the right option. But in some cases, they are not immediately necessary, especially with more minor injuries and… Read More »
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). The most recent results from the trial will be presented today at the 60th American… Read More »
SAN DIEGO (Reuters) – Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta continued to respond to the cell therapy after at least two years of follow up, the company said on Sunday. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May… Read More »